DE102008033327A1 - Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik - Google Patents

Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik Download PDF

Info

Publication number
DE102008033327A1
DE102008033327A1 DE102008033327A DE102008033327A DE102008033327A1 DE 102008033327 A1 DE102008033327 A1 DE 102008033327A1 DE 102008033327 A DE102008033327 A DE 102008033327A DE 102008033327 A DE102008033327 A DE 102008033327A DE 102008033327 A1 DE102008033327 A1 DE 102008033327A1
Authority
DE
Germany
Prior art keywords
cells
material according
biodegradable
silica sol
fibers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE102008033327A
Other languages
German (de)
English (en)
Inventor
Iwer Baecker
Holger Dr. Egger
Miranda Rothenburger-Glaubitt
Joern Dr. Probst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Innovation GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Innovation GmbH filed Critical Bayer Innovation GmbH
Priority to DE102008033327A priority Critical patent/DE102008033327A1/de
Priority to PCT/EP2009/004806 priority patent/WO2010006708A1/de
Priority to CA2730697A priority patent/CA2730697C/en
Priority to RU2011105299/04A priority patent/RU2512512C2/ru
Priority to CN2009801361358A priority patent/CN102159623A/zh
Priority to MX2011000475A priority patent/MX2011000475A/es
Priority to KR1020117000993A priority patent/KR20110039533A/ko
Priority to JP2011517774A priority patent/JP2011527913A/ja
Priority to EP09776935.0A priority patent/EP2303948B1/de
Priority to BRPI0915946-0A priority patent/BRPI0915946A2/pt
Priority to AU2009270515A priority patent/AU2009270515A1/en
Priority to US13/054,449 priority patent/US20110123596A1/en
Publication of DE102008033327A1 publication Critical patent/DE102008033327A1/de
Priority to IL210313A priority patent/IL210313A0/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/06—Preparatory processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/62227—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres
    • C04B35/62231—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres based on oxide ceramics
    • C04B35/6224—Fibres based on silica
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/40—Metallic constituents or additives not added as binding phase
    • C04B2235/408—Noble metals
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/44—Metal salt constituents or additives chosen for the nature of the anions, e.g. hydrides or acetylacetonate
    • C04B2235/441—Alkoxides, e.g. methoxide, tert-butoxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Ceramic Engineering (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Structural Engineering (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Polymers (AREA)
  • Inorganic Fibers (AREA)
  • Silicon Compounds (AREA)
DE102008033327A 2008-07-16 2008-07-16 Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik Ceased DE102008033327A1 (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
DE102008033327A DE102008033327A1 (de) 2008-07-16 2008-07-16 Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik
JP2011517774A JP2011527913A (ja) 2008-07-16 2009-07-03 ヒト用医薬および/または医療技術のための生分解性および/または吸収性のシリカゲル材料の製造のための少なくとも1種類の治療活性成分を含むシリカゾル材料
EP09776935.0A EP2303948B1 (de) 2008-07-16 2009-07-03 Verfahren zur herstellung eines kieselsol-materials mit mindestens einem therapeutisch aktiven wirkstoff zur herstellung von biologisch degradierbaren und/oder resorbierbaren kieselgel-materialen für die humanmedizin und/oder medizintechnik
RU2011105299/04A RU2512512C2 (ru) 2008-07-16 2009-07-03 Кизельзоль-материал по меньшей мере с одним терапев-тически активным веществом для получения биологиче-ски разлагаемых и/или впитываемых кизельгель-материалов для медицины человека и/или медтехники
CN2009801361358A CN102159623A (zh) 2008-07-16 2009-07-03 用于人医药和/或医学技术的可生物降解和/或可吸收性硅凝胶材料的生产中的含有至少一种治疗活性成分的硅溶胶材料
MX2011000475A MX2011000475A (es) 2008-07-16 2009-07-03 Material de sol de silice con al menos un principio activo terapeutico para la obtencion de materiales de gel de silice biodegradables y/o biorreabsorbibles para la medicina humana y/o la tecnologia medica.
KR1020117000993A KR20110039533A (ko) 2008-07-16 2009-07-03 인간 약품 및/또는 의료 기술을 위한 생물학적 분해성 및/또는 재흡수성 실리카겔 물질을 제조하기 위한 하나 이상의 치료학적 활성 물질을 갖는 실리카졸 물질
PCT/EP2009/004806 WO2010006708A1 (de) 2008-07-16 2009-07-03 Kieselsol-material mit mindestens einem therapeutisch aktiven wirkstoff zur herstellung von biologisch degradierbaren und/oder resorbierbaren kieselgel-materialen für die humanmedizin und/oder medizintechnik
CA2730697A CA2730697C (en) 2008-07-16 2009-07-03 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology
BRPI0915946-0A BRPI0915946A2 (pt) 2008-07-16 2009-07-03 material de sol de silíca com pelo menos uma substância teurapeuticamente ativa para a preparação de materiais de gel de sílica biologicamente degradáveis e/ou reabsrovíveis para a medicina e/ou tecnologia médica
AU2009270515A AU2009270515A1 (en) 2008-07-16 2009-07-03 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology
US13/054,449 US20110123596A1 (en) 2008-07-16 2009-07-03 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology
IL210313A IL210313A0 (en) 2008-07-16 2010-12-28 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102008033327A DE102008033327A1 (de) 2008-07-16 2008-07-16 Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik

Publications (1)

Publication Number Publication Date
DE102008033327A1 true DE102008033327A1 (de) 2010-01-21

Family

ID=41011815

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102008033327A Ceased DE102008033327A1 (de) 2008-07-16 2008-07-16 Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik

Country Status (13)

Country Link
US (1) US20110123596A1 (cg-RX-API-DMAC7.html)
EP (1) EP2303948B1 (cg-RX-API-DMAC7.html)
JP (1) JP2011527913A (cg-RX-API-DMAC7.html)
KR (1) KR20110039533A (cg-RX-API-DMAC7.html)
CN (1) CN102159623A (cg-RX-API-DMAC7.html)
AU (1) AU2009270515A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0915946A2 (cg-RX-API-DMAC7.html)
CA (1) CA2730697C (cg-RX-API-DMAC7.html)
DE (1) DE102008033327A1 (cg-RX-API-DMAC7.html)
IL (1) IL210313A0 (cg-RX-API-DMAC7.html)
MX (1) MX2011000475A (cg-RX-API-DMAC7.html)
RU (1) RU2512512C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010006708A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025040679A1 (de) * 2023-08-22 2025-02-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Kieselsäure freisetzende faser oder faserfragmente, hieraus hergestellte faservliese sowie formulierung
DE102024209914A1 (de) 2024-10-11 2026-04-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Lösung zur Herstellung einer bioabbaubaren Beschichtung, Verfahren zu ihrer Herstellung, Verfahren zur Beschichtung eines Substrates sowie damit hergestellter beschichteter Gegenstand

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010008982A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie
DE102010008981A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie
DE102010023336A1 (de) * 2010-06-10 2011-12-15 Bayer Innovation Gmbh Verfahren zur Herstellung eines Kieselsol-Materials
MX382405B (es) 2010-07-02 2025-03-13 Procter & Gamble Método para suministrar un agente activo.
EP3533908B1 (en) 2010-07-02 2026-07-01 The Procter & Gamble Company NONWOVEN FABRIC COMPRISING ONE OR MORE ACTIVE AGENTS
JP5859526B2 (ja) 2010-07-02 2016-02-10 ザ プロクター アンド ギャンブルカンパニー 活性剤不織布ウェブを含むフィラメント及びその製造方法
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
BR112012033600A2 (pt) * 2010-07-02 2016-11-29 Procter & Gamble Comapny filamentos compreendendo mantas de não-tecido com agente ingerível e métodos de fabricação dos mesmos.
US20140065221A1 (en) * 2011-03-31 2014-03-06 Galderma Research & Development Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
FI20155779A7 (fi) * 2015-10-30 2017-05-01 Solani Therapeutics Ltd Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu
CN110191700A (zh) 2017-01-27 2019-08-30 宝洁公司 可溶性固体结构形式的组合物
CN110167639B (zh) 2017-01-27 2022-10-14 宝洁公司 呈包含泡腾型附聚颗粒的可溶性固体结构形式的组合物
JP6923673B2 (ja) 2017-05-16 2021-08-25 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 溶解性固形構造体の形態のコンディショニングヘアケア組成物
DE102017009989A1 (de) * 2017-10-26 2019-05-02 Carl Freudenberg Kg Biokompatibles Verbundmaterial zum Einbringen in einen menschlichen Körper
US20190255223A1 (en) * 2018-02-16 2019-08-22 American Nano, LLC Silica fiber compositions and methods of use
CN108283707B (zh) * 2018-04-05 2021-03-26 广西中医药大学 一种瑶药退烧贴及其制备方法
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
JP7381613B2 (ja) 2019-06-28 2023-11-15 ザ プロクター アンド ギャンブル カンパニー アニオン性界面活性剤を含有する溶解性固体繊維性物品
WO2022027067A1 (en) 2020-07-31 2022-02-03 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care
CN113332488A (zh) * 2021-05-31 2021-09-03 南昌智产科技有限公司 一种医用硅凝胶泡沫敷料及其制备方法
EP4395730A1 (en) 2021-08-30 2024-07-10 The Procter & Gamble Company Dissolvable solid structure comprising first and second polymeric structurants
US12576013B2 (en) 2021-12-17 2026-03-17 The Procter & Gamble Company Dissolvable solid fibrous shampoo articles containing salts
CN114404660A (zh) * 2022-01-21 2022-04-29 江苏信立康医疗科技有限公司 一种基于三维支架的细胞培养方法
US12540238B2 (en) 2022-03-10 2026-02-03 The Procter & Gamble Company Dissolvable solid structure having first and second layers
CN115531592A (zh) * 2022-10-27 2022-12-30 李升红 一种实现皮肤高效修复的皮肤敷料及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19609551C1 (de) 1996-03-12 1997-07-17 Fraunhofer Ges Forschung Biologisch degradierbare und/oder biologisch resorbierbare (Endlos)Fasern, Verfahren zu deren Herstellung und deren Verwendung als Verstärkungsfasern
DE102004063599A1 (de) 2004-12-30 2006-07-13 Bayer Innovation Gmbh Verkürzte Wundheilungsprozesse mittels neuartiger Faservliese

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764690B2 (en) * 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
NZ332968A (en) * 1996-05-29 2000-08-25 Bioxid Oy A controllably dissolvable silica-xerogel prepared via sol-gel
CA2328614C (en) * 1999-02-12 2012-06-26 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
AU764663C (en) * 1999-02-22 2005-02-03 Bayer Innovation Gmbh Biodegradable ceramic fibres from silica sols
US7118921B1 (en) * 1999-06-24 2006-10-10 Mcmaster University Incorporation and applications of biomolecular interactions within a carrier
CA2377560C (en) * 1999-06-24 2010-08-24 Mcmaster University Incorporation and applications of biomolecular interactions within a carrier
DE10126137C1 (de) * 2001-05-29 2002-11-07 Andreas Haisch Verfahren zur Herstellung von Zellen, Geweben und Organen
DE102007061873B4 (de) * 2007-01-15 2025-06-26 Bayer Intellectual Property Gmbh Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien, dessen Herstellung und Verwendung
EP2111417B1 (de) * 2007-01-16 2011-11-30 Basf Se Verfahren zur herstellung von polymerpartikeln durch polymerisation von flüssigkeitstropfen in einer gasphase

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19609551C1 (de) 1996-03-12 1997-07-17 Fraunhofer Ges Forschung Biologisch degradierbare und/oder biologisch resorbierbare (Endlos)Fasern, Verfahren zu deren Herstellung und deren Verwendung als Verstärkungsfasern
DE102004063599A1 (de) 2004-12-30 2006-07-13 Bayer Innovation Gmbh Verkürzte Wundheilungsprozesse mittels neuartiger Faservliese

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EN 30993-5 (1994)
ISO 10993-5 (1999)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025040679A1 (de) * 2023-08-22 2025-02-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Kieselsäure freisetzende faser oder faserfragmente, hieraus hergestellte faservliese sowie formulierung
DE102024209914A1 (de) 2024-10-11 2026-04-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Lösung zur Herstellung einer bioabbaubaren Beschichtung, Verfahren zu ihrer Herstellung, Verfahren zur Beschichtung eines Substrates sowie damit hergestellter beschichteter Gegenstand

Also Published As

Publication number Publication date
RU2011105299A (ru) 2012-08-27
WO2010006708A1 (de) 2010-01-21
US20110123596A1 (en) 2011-05-26
IL210313A0 (en) 2011-03-31
BRPI0915946A2 (pt) 2019-04-09
CA2730697A1 (en) 2010-01-21
EP2303948B1 (de) 2018-09-12
CN102159623A (zh) 2011-08-17
CA2730697C (en) 2016-10-25
RU2512512C2 (ru) 2014-04-10
MX2011000475A (es) 2011-03-15
AU2009270515A1 (en) 2010-01-21
JP2011527913A (ja) 2011-11-10
KR20110039533A (ko) 2011-04-19
EP2303948A1 (de) 2011-04-06

Similar Documents

Publication Publication Date Title
EP2303948B1 (de) Verfahren zur herstellung eines kieselsol-materials mit mindestens einem therapeutisch aktiven wirkstoff zur herstellung von biologisch degradierbaren und/oder resorbierbaren kieselgel-materialen für die humanmedizin und/oder medizintechnik
DE102007061873B4 (de) Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien, dessen Herstellung und Verwendung
Zahiri et al. Encapsulation of curcumin loaded chitosan nanoparticle within poly (ε-caprolactone) and gelatin fiber mat for wound healing and layered dermal reconstitution
Pedram Rad et al. Preparation and characterization of Calendula officinalis-loaded PCL/gum arabic nanocomposite scaffolds for wound healing applications
Jahani et al. Antibacterial and wound healing stimulant nanofibrous dressing consisting of soluplus and soy protein isolate loaded with mupirocin
KR101101321B1 (ko) 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
Sadeghi-Soureh et al. Potential of Chrysin‐loaded PCL/gelatin nanofibers for modulation of macrophage functional polarity towards anti-inflammatory/pro-regenerative phenotype
Khan et al. Electrospinning of crude plant extracts for antibacterial and wound healing applications: a review
Datta et al. Oleoyl-chitosan-based nanofiber mats impregnated with amniotic membrane derived stem cells for accelerated full-thickness excisional wound healing
Marjani et al. CDI crosslinked chitosan/poly (vinyl alcohol) electrospun nanofibers loaded with Achillea millefolium and Viola extract: A promising wound dressing
DE102007026043B4 (de) Nicht-toxisches Polyethoxysiloxan-Material zur Herstellung von biologisch resorbierbares und/oder bioaktives Polyethoxysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung
Dwivedi et al. Fabrication and assessment of gentamicin loaded electrospun nanofibrous scaffolds as a quick wound healing dressing material
EP3692191B1 (de) Hochflexible degradierbare fasern
Sellappan et al. Fabrication of dual layered biocompatible herbal biopatch from biological waste for skin-tissue regenerative applications
WO2014095915A1 (de) Kettenverlängerte poloxamere, daraus gebildete thermoreversible hydrogele mit biologischen materialien, und medizinische anwendungen derselben
Rajora et al. Evaluating neem gum-polyvinyl alcohol (NGP-PVA) blend nanofiber mat as a novel platform for wound healing in murine model
EP2225180B1 (de) Nicht-toxisches polysiloxan-material zur herstellung von biologisch resorbierbaren und/oder bioaktiven polysiloxan-material enthaltenden artikeln
Scalia et al. Multifunctional eugenol-enriched PEO-based electrospun and photo-crosslinked scaffolds for wound healing applications
DE102020205823A1 (de) Aufbau einer physiologischen Haut-Material-Konnektion
Murali et al. Chitosan nanofibers in regenerative medicine
Cao-Luu et al. Multifunctional triple-layer nanofiber membrane for accelerated skin wound regeneration–Preparation, characterization, in vitro and in vivo studies
Çakmen et al. Fabrication and characterization of high molecular mass tmpe-based polyurethane wound dressing materials containing allantoin and gentamicin by electrospinning
Khumfu et al. Development of Poly (lactic acid)/Poly (ethylene glycol) Nanofibers for Wound Healing Patch with Anti-bacterial and Anti-inflammatory Properties

Legal Events

Date Code Title Description
R081 Change of applicant/patentee

Owner name: BAYER INNOVATION GMBH, DE

Free format text: FORMER OWNER: BAYER INNOVATION GMBH, 40225 DUESSELDORF, DE

Effective date: 20130118

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

Free format text: FORMER OWNER: BAYER INNOVATION GMBH, 40225 DUESSELDORF, DE

Effective date: 20130118

R012 Request for examination validly filed
R081 Change of applicant/patentee

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

Free format text: FORMER OWNER: BAYER INNOVATION GMBH, 51373 LEVERKUSEN, DE

R082 Change of representative

Representative=s name: KUTZENBERGER WOLFF & PARTNER PATENTANWALTSPART, DE

R016 Response to examination communication
R002 Refusal decision in examination/registration proceedings
R003 Refusal decision now final